{
    "root": "35bbb655-19e3-00c2-e063-6394a90afbe3",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Tamsulosin hydrochloride",
    "value": "20250522",
    "ingredients": [
        {
            "name": "METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER",
            "code": "NX76LV5T8J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25219"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_168426"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "DEHYDRATED ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "AMMONIUM CATION",
            "code": "54S68520I4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28938"
        },
        {
            "name": "TAMSULOSIN HYDROCHLORIDE",
            "code": "11SV1951MR",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9399"
        }
    ],
    "indications": {
        "text": "tamsulosin hydrochloride capsules indicated treatment signs symptoms benign prostatic hyperplasia ( bph ) [ ( 14 ) ] . tamsulosin hydrochloride capsules indicated treatment hypertension .",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "tamsulosin hydrochloride capsules 0.4 mg daily recommended dose treatment signs symptoms bph . administered approximately one-half hour following meal day . tamsulosin hydrochloride capsules crushed , chewed opened . patients fail respond 0.4 mg dose 2 4 weeks dosing , dose tamsulosin hydrochloride capsules increased 0.8 mg daily . tamsulosin hydrochloride capsules 0.4 mg used combination strong inhibitors cyp3a4 ( e.g . , ketoconazole ) [ ( 5.2 ) ] . tamsulosin hydrochloride capsules discontinued interrupted several days either 0.4 mg 0.8 mg dose , therapy started 0.4 mg once-daily dose .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "tamsulosin hydrochloride capsules usp , 0.4 mg supplied high density polyethylene bottles containing 90 , 500 hard gelatin capsules olive green opaque cap orange opaque body . cap imprinted code \u201c tsl 0.4 \u201d black ink . bottle 90 capsules ( ndc 76282-744-90 ) bottle 500 capsules ( ndc 76282-744-05 ) store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c\u201330\u00b0c ( 59\u00b0f\u201386\u00b0f ) [ usp controlled room temperature ] . keep tamsulosin hydrochloride capsules , usp medicines reach children .",
    "adverseReactions": "tamsulosin hydrochloride capsules contraindicated patients known hypersensitive tamsulosin hydrochloride component tamsulosin hydrochloride capsules . included skin rash , urticaria , pruritus , angioedema , respiratory symptoms [ ( 6.2 ) ] .",
    "indications_original": "Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH)\n \n  [see Clinical Studies (\n  \n   14)].\n \n  \u00a0Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension.",
    "contraindications_original": "Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules should not be crushed, chewed or opened.\n                  For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole)\n \n  [see Warnings and Precautions (\n  \n   5.2)]\n \n  .\n\n \n                  If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.",
    "warningsAndPrecautions_original": "Tamsulosin hydrochloride capsules USP, 0.4 mg are supplied in high density polyethylene bottles containing 90, 500 hard gelatin capsules with an olive green opaque cap and an orange opaque body. The cap is imprinted with the code \u201cTSL 0.4\u201d in black ink.\n                  Bottle of 90 capsules (NDC 76282-744-90)\n                  Bottle of 500 capsules (NDC 76282-744-05)\n                  \n                     Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C\u201330\u00b0C (59\u00b0F\u201386\u00b0F)[see USP Controlled Room Temperature].\n\n \n                  Keep tamsulosin hydrochloride capsules, USP and all medicines out of reach of children.",
    "adverseReactions_original": "Tamsulosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to tamsulosin hydrochloride or any component of tamsulosin hydrochloride capsules. Reactions have included skin rash, urticaria, pruritus, angioedema, and respiratory symptoms\n \n  [see Adverse Reactions (\n  \n   6.2)].",
    "drug": [
        {
            "name": "Tamsulosin hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9399"
        }
    ]
}